Filed Pursuant to Rule 424(b)(3)
Registration No. 333-275133
Prospectus
VinFast Auto Ltd.
95,273,331 Ordinary Shares
This prospectus relates to the offer and sale, from time to time, by YA II PN, Ltd., a Cayman Islands exempted company (“Yorkville”), of up to 95,273,331 ordinary shares in the capital of VinFast Auto Ltd., a public company incorporated under the laws of Singapore (Company Registration No: 201501874G) (“we,” “us,” the “Company” or “VinFast”), no par value (“ordinary shares”) that we may, at our discretion, elect to issue to Yorkville from time to time after the date of this prospectus, pursuant to the Standby Equity Subscription Agreement, dated as of October 20, 2023, entered into by and between Yorkville and the Company (the “Yorkville Subscription Agreement”). See “Committed Equity Financing” for a description of the Yorkville Subscription Agreement and “Selling Securityholder” for additional information regarding Yorkville.
Under the Yorkville Subscription Agreement, we have the right, but not the obligation, to issue to Yorkville, and Yorkville has the obligation to subscribe for, ordinary shares for an aggregate subscription amount of up to $1.0 billion (the “Commitment Amount”), at any time from the date of the Yorkville Subscription Agreement until November 1, 2026, unless earlier terminated pursuant to the Yorkville Subscription Agreement (the “Commitment Period”), subject to certain conditions. We do not have the right to require Yorkville to subscribe for any ordinary shares under the Yorkville Subscription Agreement until the date on which all of the conditions to Yorkville’s subscription obligation set forth in the Yorkville Subscription Agreement have been satisfied, including that the registration statement of which this prospectus forms a part be declared effective by the SEC and the final form of this prospectus is filed with the SEC. From and after such date, we will have the right, but not the obligation, from time to time at our discretion during the Commitment Period, to require Yorkville to subscribe for a specified amount of ordinary shares (each such issuance, an “Advance”) by delivering written notice to Yorkville (each, an “Advance Notice”). Each Advance is subject to a maximum limit of an amount equal to 100% of the average of the daily trading volume of our ordinary shares on Nasdaq Stock Market LLC (“Nasdaq”) for the five trading days immediately preceding the delivery of an Advance Notice from us to Yorkville.
Under applicable rules of the Nasdaq and the Yorkville Subscription Agreement, in no event may we issue to Yorkville ordinary shares that would result in the number of our ordinary shares issued under the Yorkville Subscription Agreement exceeding 466,212,650 ordinary shares (the “Exchange Cap”), being 19.99% of our ordinary shares issued as of October 19, 2023, unless (a) we obtain shareholder approval to issue ordinary shares in excess of the Exchange Cap or (b) the average price of all applicable issuances of ordinary shares hereunder (including the 800,000 ordinary shares (the “Commitment Shares”) issued by us to Yorkville on November 3, 2023 as consideration for its irrevocable commitment to subscribe for ordinary shares at our direction, from time to time, upon the terms and subject to the conditions set forth in the Yorkville Subscription Agreement) equals or exceeds $5.69 (being the reference price under Nasdaq Rules) per share (which represents the lower of (i) the Nasdaq Official Closing Price (as reflected on Nasdaq.com) immediately preceding the signing of the Yorkville Subscription Agreement; or (ii) the average Nasdaq Official Closing Price of our ordinary shares (as reflected on Nasdaq.com) for the five trading days immediately preceding the signing of the Yorkville Subscription Agreement). In any event, we may not issue any ordinary shares under the Yorkville Subscription Agreement if such issuance would breach any applicable Nasdaq listing rules.
The Yorkville Subscription Agreement does not obligate Yorkville to subscribe for or acquire any ordinary shares under the Yorkville Subscription Agreement if those ordinary shares, when aggregated with all other ordinary shares acquired by Yorkville under the Yorkville Subscription Agreement, would result in Yorkville beneficially owning more than 4.99% of the then outstanding ordinary shares (the “Beneficial Ownership Cap”).
Each ordinary share to be issued to Yorkville from time to time under the Yorkville Subscription Agreement will be issued at 97.5% of the Market Price, as defined in the Yorkville Subscription Agreement. “Market Price” is defined as the lowest of the daily volume weighted average prices (“VWAP”) during the three consecutive trading days commencing on the advance notice date (“Pricing Period”), other than the daily VWAP on any day excluded pursuant to the terms of the Yorkville Subscription Agreement. With respect to each Advance, if VinFast notifies Yorkville of a minimum acceptable price with respect to such Advance, then if the VWAP of the ordinary shares is below the minimum acceptable price indicated by VinFast or if there is no VWAP, there will be an automatic reduction to the amount of the Advance by one third, and that day will be excluded from the Pricing Period. The total number of ordinary shares to be issued to Yorkville in respect of each Advance with any excluded days will be increased by such number of ordinary shares equal to the greater of the number of ordinary shares, if any, sold by Yorkville on such excluded days or such number of ordinary shares that Yorkville elects to subscribe for, in each case, at a subscription price per ordinary share equal to 97.5% of the minimum acceptable price, subject to the limitations set forth in the Yorkville Subscription Agreement.
We may not have access to the full $1.0 billion Commitment Amount available under the Yorkville Subscription Agreement due to the reasons noted above. See “Committed Equity Financing” for more information regarding the Yorkville Subscription Agreement.
We are not selling any of our ordinary shares under this prospectus, and we will not receive any of the proceeds from the sale of our ordinary shares by Yorkville. We will bear all costs, expenses and fees in connection with the registration of the ordinary shares. Yorkville will bear all commissions and discounts, if any, attributable to sales of the ordinary shares registered herein. We are registering these our ordinary shares for resale by Yorkville pursuant to the registration rights granted to Yorkville under the Yorkville Subscription Agreement. See “Selling Securityholder” for more information.
Our registration of the securities covered by this prospectus does not mean that Yorkville will offer or sell any of the ordinary shares. Yorkville may offer and sell the securities covered by this prospectus in a number of different ways and at varying prices. See “Plan of Distribution” for more information. As of the date of this prospectus, we are unable to estimate the actual amount of proceeds that we may receive under the Yorkville Subscription Agreement, as it will depend on a number of factors, including the frequency and prices at which we issue ordinary shares to Yorkville, market conditions and the trading price of our ordinary shares, our ability to meet the conditions set forth in the Yorkville Subscription Agreement, and determinations by us as to the appropriate sources of funding for our company and our operations.
The 95,273,331 ordinary shares offered by Yorkville pursuant to this Second Resale Registration Statement (as defined herein), together with the 34,929,486 Affiliate Resale Shares (as defined herein) offered by the selling securityholders named in the First Resale Registration Statement (as defined herein) and the 5,100,000 ordinary shares offered by Yorkville pursuant to the Third Resale Registration Statement (as defined herein), represent 5.8% of our outstanding ordinary shares as of March 27, 2024. The number of ordinary shares registered for resale pursuant to the First Resale Registration Statement, this Second Resale Registration Statement and the Third Resale Registration Statement collectively constitute approximately 7.7 times the number of ordinary shares held by persons other than the selling securityholders named herein and therein and our affiliates. Accordingly, sales of our ordinary shares pursuant to the First Resale Registration Statement, this Second Resale Registration and the Third Resale Registration Statement could be significant, relative to our current public float. The market price of our ordinary shares could decline if Yorkville sells a significant portion of our ordinary shares or is perceived by the market as intending to sell them. See “Risk Factors — Risks Relating to our Ordinary Shares — The issuance of ordinary shares to Yorkville under the Yorkville Subscription Agreement, the conversion of the Convertible Debenture or the exchange of the Exchangeable Bonds may result in the dilution of our shareholders and create downward pressure on the price of our ordinary shares” and “Risk Factors — Risks Relating to this Offering — Investors who buy ordinary shares at different times will likely pay different prices.”
Yorkville is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended (the “Securities Act”), and any profits on the sales of shares of our ordinary shares by Yorkville and any discounts, commissions, or concessions received by Yorkville are deemed to be underwriting discounts and commissions under the Securities Act. If any underwriters, dealers or agents are involved in the sale of any of the securities, their names and any applicable purchase price, fee, commission or discount arrangement between or among them will be set forth, or will be calculable from the information set forth, in any applicable prospectus supplement. See the sections of this prospectus titled “About this Prospectus” and “Plan of Distribution” for more information. No securities may be sold without delivery of this prospectus and any applicable prospectus supplement describing the method and terms of the offering of such securities. You should carefully read this prospectus and any applicable prospectus supplement before you invest in our securities.
Our ordinary shares and warrants are listed on the Nasdaq under the symbols, “VFS” and “VFSWW.” We had 2,337,865,164 ordinary shares and 3,321,002 warrants outstanding as of March 27, 2024. On March 27, 2024, the last reported sale price of our ordinary shares and warrants as reported on Nasdaq were $4.73 per ordinary share and $0.69 per warrant.
We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read this entire prospectus and any amendments or supplements carefully before you make your investment decision.
We are both an “emerging growth company” and a “foreign private issuer” as defined under the U.S. federal securities laws and, as such, may elect to comply with certain reduced public company reporting requirements. See “Prospectus Summary — Implication of Being a Foreign Private Issuer” and “Prospectus Summary — Implication of Being an Emerging Growth Company.”
Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 11 of this prospectus for a discussion of information that should be considered in connection with an investment in our securities. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
Prospectus dated April 5, 2024.